InvestorsHub Logo
Followers 5
Posts 861
Boards Moderated 0
Alias Born 02/23/2017

Re: None

Monday, 12/09/2019 11:53:05 AM

Monday, December 09, 2019 11:53:05 AM

Post# of 492
Sanofi buys biotech THOR for $67/sh. THOR has no sales and is losing big money. Equating sh count to LexaGene is $18/sh.
That is very encouraging.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.